Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...

Donald Trump took a major action on Monday to significantly reduce the cost Americans pay for pharmaceuticals and ...

The initial valuation of US$197.1 million in 2023 is expected to grow as industries emerge to take advantage of the superior processing power of quantum computing. The integration of quantum ...

Mike Heffernan appointed as Chairman of the Board <li /> Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidrade ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs. The company expects to employ 420 ...

Mike Heffernan appointed as Chairman of the Board Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Cash on hand of approximately $125 mi ...

Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the crown jewel of US biomedical research with ideology and cronyism.

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

CROs Advance Pharmaceutical Innovation with Thermo Fisher Scientific In today’s fast-paced pharmaceutical landscape, Contract ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

Research into chemical discovery, testing optimization and analysis can be a labor-intensive and time-consuming process. With ...